Status:

NOT_YET_RECRUITING

Prospective Opioid-Free AIS Fusion

Lead Sponsor:

OrthoCarolina Research Institute, Inc.

Conditions:

Adolescent Idiopathic Scoliosis (AIS)

Eligibility:

All Genders

10-20 years

Phase:

PHASE4

Brief Summary

The purpose of this study is to compare the efficacy of a multimodal opioid-free (OF) pain management protocol with a traditional opioid-containing (OC) protocol in pediatric patients undergoing instr...

Detailed Description

Opioids are the most common controlled medication used medically and non-medically by adolescents in the United States. Opioid prescribing practices are inextricably linked with the ongoing public hea...

Eligibility Criteria

Inclusion

  • Pediatric patients (10-20 years of age at the time of surgery)
  • Diagnosis of idiopathic scoliosis
  • Undergoing primary instrumented PSF

Exclusion

  • Age \<10 years or \>20 years at time of surgery
  • Patients with non-idiopathic scoliosis etiology, ie neuromuscular or syndromic scoliosis
  • Patients undergoing non-fusion spinal surgeries, ie growing rods or tethering

Key Trial Info

Start Date :

August 15 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2027

Estimated Enrollment :

58 Patients enrolled

Trial Details

Trial ID

NCT06935331

Start Date

August 15 2025

End Date

December 31 2027

Last Update

August 3 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

OrthoCarolina Research Institute

Charlotte, North Carolina, United States, 28207

Prospective Opioid-Free AIS Fusion | DecenTrialz